These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 26853494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
    Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V.
    Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
    [Abstract] [Full Text] [Related]

  • 5. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
    Dragon J, Thompson J, MacPherson M, Shukla A.
    J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
    Sementino E, Menges CW, Kadariya Y, Peri S, Xu J, Liu Z, Wilkes RG, Cai KQ, Rauscher FJ, Klein-Szanto AJ, Testa JR.
    J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
    Chirac P, Maillet D, Leprêtre F, Isaac S, Glehen O, Figeac M, Villeneuve L, Péron J, Gibson F, Galateau-Sallé F, Gilly FN, Brevet M.
    Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.
    Kukuyan AM, Sementino E, Kadariya Y, Menges CW, Cheung M, Tan Y, Cai KQ, Slifker MJ, Peri S, Klein-Szanto AJ, Rauscher FJ, Testa JR.
    Cancer Res; 2019 Aug 15; 79(16):4113-4123. PubMed ID: 31151962
    [Abstract] [Full Text] [Related]

  • 10. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T, Hatanaka Y, Marukawa K, Okada H, Hatanaka KC, Sakakibara-Konishi J, Oizumi S, Hida Y, Kaga K, Mitsuhashi T, Matsuno Y.
    Diagn Pathol; 2016 Apr 18; 11():38. PubMed ID: 27091358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.
    Desmeules P, Joubert P, Zhang L, Al-Ahmadie HA, Fletcher CD, Vakiani E, Delair DF, Rekhtman N, Ladanyi M, Travis WD, Antonescu CR.
    Am J Surg Pathol; 2017 Jul 18; 41(7):980-988. PubMed ID: 28505004
    [Abstract] [Full Text] [Related]

  • 15. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.
    Mäki-Nevala S, Sarhadi VK, Knuuttila A, Scheinin I, Ellonen P, Lagström S, Rönty M, Kettunen E, Husgafvel-Pursiainen K, Wolff H, Knuutila S.
    Lung; 2016 Feb 18; 194(1):125-35. PubMed ID: 26463840
    [Abstract] [Full Text] [Related]

  • 16. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
    Kettunen E, Savukoski S, Salmenkivi K, Böhling T, Vanhala E, Kuosma E, Anttila S, Wolff H.
    BMC Cancer; 2019 May 28; 19(1):507. PubMed ID: 31138176
    [Abstract] [Full Text] [Related]

  • 17. Malignant Mesothelioma and Its Non-Asbestos Causes.
    Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL.
    Arch Pathol Lab Med; 2018 Jun 28; 142(6):753-760. PubMed ID: 29480760
    [Abstract] [Full Text] [Related]

  • 18. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
    Sneddon S, Patch AM, Dick IM, Kazakoff S, Pearson JV, Waddell N, Allcock RJN, Holt RA, Robinson BWS, Creaney J.
    BMC Cancer; 2017 Jun 02; 17(1):396. PubMed ID: 28577549
    [Abstract] [Full Text] [Related]

  • 19. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI, Tjota MY, Gao G, Mitchell O, Kindler H, Segal J, Husain AN, Mueller J, Schulte JJ.
    Am J Clin Pathol; 2023 Sep 01; 160(3):238-246. PubMed ID: 37141416
    [Abstract] [Full Text] [Related]

  • 20. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
    Hung YP, Dong F, Watkins JC, Nardi V, Bueno R, Dal Cin P, Godleski JJ, Crum CP, Chirieac LR.
    JAMA Oncol; 2018 Feb 01; 4(2):235-238. PubMed ID: 28910456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.